Literature DB >> 12237080

Transfection technology and the study of drug resistance in the malaria parasite Plasmodium falciparum.

Brendan S Crabb1.   

Abstract

Numerous approaches have been employed to identify the molecules responsible for drug resistance in the human malaria parasite Plasmodium falciparum. However, it was not until the recent development of stable transfection in this parasite that it became possible to prove the role of particular genes in drug resistance and, perhaps more importantly, to characterise the nature of the specific mutations that contribute the resistance phenotype. In this review, the contribution of various molecular genetic approaches to the dissection of drug resistance in P. falciparum is described. Future possibilities in this field are also outlined in the light of recent technological advances.

Entities:  

Mesh:

Year:  2002        PMID: 12237080     DOI: 10.1016/s1368-7646(02)00085-7

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  12 in total

1.  Tetracycline analogue-regulated transgene expression in Plasmodium falciparum blood stages using Toxoplasma gondii transactivators.

Authors:  Markus Meissner; Efrosinia Krejany; Paul R Gilson; Tania F de Koning-Ward; Dominique Soldati; Brendan S Crabb
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

2.  Plasmodium falciparum: development of a transgenic line for screening antimalarials using firefly luciferase as the reporter.

Authors:  Long Cui; Jun Miao; Jiaxu Wang; Qianjun Li; Liwang Cui
Journal:  Exp Parasitol       Date:  2008-05-29       Impact factor: 2.011

3.  Centenary celebrations article: Cysteine proteases of human malaria parasites.

Authors:  Kailash C Pandey
Journal:  J Parasit Dis       Date:  2011-12-03

Review 4.  Drug-resistant malaria.

Authors:  John E Hyde
Journal:  Trends Parasitol       Date:  2005-09-02

Review 5.  Targeting purine and pyrimidine metabolism in human apicomplexan parasites.

Authors:  John E Hyde
Journal:  Curr Drug Targets       Date:  2007-01       Impact factor: 3.465

Review 6.  Drug-resistant malaria - an insight.

Authors:  John E Hyde
Journal:  FEBS J       Date:  2007-09       Impact factor: 5.542

Review 7.  Molecular epidemiology of malaria.

Authors:  David J Conway
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

8.  Expression profile of the Plasmodium falciparum intra-erythrocytic stage protein, PF3D7_1363700.

Authors:  Renee N Roberts; Maggie S Schlarman; Michael M Kariuki; Alexis N Lacrue; Ruguang Ou; Brenda T Beerntsen
Journal:  Malar J       Date:  2013-02-19       Impact factor: 2.979

9.  Plasmodium falciparum glutamate dehydrogenase a is dispensable and not a drug target during erythrocytic development.

Authors:  Janet Storm; Jan Perner; Isabela Aparicio; Eva-Maria Patzewitz; Kellen Olszewski; Manuel Llinas; Paul C Engel; Sylke Müller
Journal:  Malar J       Date:  2011-07-14       Impact factor: 2.979

10.  Structure-function of falcipains: malarial cysteine proteases.

Authors:  Kailash C Pandey; Rajnikant Dixit
Journal:  J Trop Med       Date:  2012-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.